Canesten Gyno (Clotrimazole)

What is Canesten Gyno?

Canesten Gyno (clotrimazole) is an antifungal medicine used to treat vaginal candidiasis, commonly referred to as vaginal thrush or a yeast infection. It is one of the most widely used antifungal treatments in Europe and is listed on the WHO Model List of Essential Medicines.

Canesten Gyno is available as vaginal pessaries (tablets inserted into the vagina) in doses of 100 mg, 200 mg, and 500 mg, as well as external cream for symptomatic relief of vulval itching and irritation. The 500 mg single-dose pessary is the most commonly prescribed formulation for convenience and adherence.

How does Canesten Gyno work?

Clotrimazole belongs to the azole class of antifungals. It works by inhibiting an enzyme called lanosterol 14-alpha-demethylase, which is essential for the synthesis of ergosterol — a critical component of the fungal cell membrane. Without adequate ergosterol:

• The fungal cell membrane becomes structurally unstable
• Cell membrane permeability increases, allowing intracellular contents to leak out
• Fungal cell growth and replication are halted (fungistatic effect)
• At higher concentrations, clotrimazole can also directly kill fungal cells (fungicidal effect)

This mechanism selectively targets fungal cells while leaving human cells largely unaffected, because human cell membranes use cholesterol rather than ergosterol as their primary sterol component.

Who is Canesten Gyno for?

Canesten Gyno is indicated for adult women with vaginal candidiasis caused by Candida species (most commonly Candida albicans). It is appropriate for women who:

• Have confirmed or strongly suspected vaginal thrush based on symptoms (itching, white cottage-cheese-like discharge, vulval soreness)
• Have previously had a confirmed diagnosis of vaginal candidiasis and recognise the same symptoms

Se recomienda evaluación médica antes del autotratamiento si:

• This is your first suspected episode of vaginal thrush
• You are pregnant or breastfeeding
• You are under 16 years of age
• You have had more than two infections in the past six months
• You have unusual symptoms (sores, abnormal discharge, pelvic pain, fever)
• You have diabetes, HIV, or are immunocompromised

Posología

The appropriate Canesten Gyno formulation depends on the severity and recurrence of the infection, as specified by the prescribing doctor.

Formulación	Dosis	Duración
Pessary 500 mg	1 pessary	Single dose (1 night)
Pessary 200 mg	1 pessary per night	3 nights
Pessary 100 mg	1 pessary per night	6 nights
Cream 2% (external)	Apply 2–3 times daily	As needed for vulval symptoms

Application: Pessaries should be inserted as high as possible into the vagina using the applicator provided, preferably at bedtime. The cream is applied externally to the vulva and surrounding skin to relieve itching.

Efectos secundarios

Canesten Gyno is generally well tolerated. Local reactions are the most commonly reported effects.

Efectos secundarios frecuentes

• Vaginal burning or stinging (particularly immediately after insertion)
• Vaginal itching (may temporarily worsen before improving)
• Vaginal discharge (may increase initially)
• Mild pelvic discomfort or cramping

Efectos secundarios poco frecuentes

• Skin rash or redness at the application site
• Vulval swelling or oedema
• Peeling or blistering of skin (with external cream)

Efectos raros pero graves

• Systemic allergic reactions are extremely rare with vaginal application due to minimal systemic absorption

If symptoms worsen significantly during treatment, discontinue use and consult a doctor.

Canesten Gyno vs alternative antifungal treatments

Tratamiento	Principio activo	Vía	Posología
Canesten Gyno	Clotrimazole	Vaginal pessary / cream	Single dose or 3–6 nights
Diflucan	Fluconazole	Oral tablet	Single 150 mg dose
Nystan	Nystatin	Vaginal pessary	14 nights
Canesten (skin)	Clotrimazole	Topical cream	For skin/nail infections

Consideraciones clave:

• Canesten Gyno vs Diflucan: Both are effective for uncomplicated vaginal candidiasis. Diflucan (fluconazole) is a single oral tablet, which some patients prefer for convenience. Canesten Gyno acts locally in the vagina with minimal systemic absorption, which may be preferred in pregnancy or for patients who cannot take oral medicines.
• Canesten Gyno vs Nystan: Nystatin requires a longer treatment course (14 days) and is generally less convenient. It is typically reserved for patients where azoles are not appropriate.

How to access Canesten Gyno online in Europe

While some Canesten Gyno formulations are available over the counter in parts of Europe, prescription access is required in many countries, and medical assessment is strongly recommended for recurring or uncertain cases.

Prescrivia opera como intermediario tecnológico: no prescribimos medicamentos, no empleamos médicos ni vendemos medicamentos. Nuestra plataforma conecta a los pacientes con médicos independientes registrados en la UE que pueden realizar evaluaciones de salud en línea confidenciales.

El proceso:

1. Complete una evaluación de salud: Describa sus síntomas y su historial de salud relevante.
2. Revisión médica: Un médico independiente registrado en la UE revisa su evaluación. If clotrimazole is appropriate, they may issue a prescription.
3. Dispensación en farmacia: La receta se envía a una farmacia asociada autorizada de la UE para su dispensación y entrega directa.

Importante: Prescrivia no garantiza que se emita una receta. Todas las decisiones de prescripción son tomadas de forma independiente por profesionales médicos cualificados.

Información importante de seguridad

Consulte a un médico antes de utilizar Canesten Gyno si usted:

• Are pregnant (especially in the first trimester — a doctor must assess suitability)
• Have symptoms that could indicate a sexually transmitted infection rather than thrush
• Have a history of recurrent vaginal infections (may indicate an underlying condition requiring investigation)
• Are using vaginal medication or a vaginal ring contraceptive

Interacciones medicamentosas: Clotrimazole can weaken latex contraceptive devices. No clinically significant drug interactions are expected with systemic medications due to minimal absorption from vaginal application.

Infecciones recurrentes: If you experience four or more episodes of vaginal candidiasis per year, a doctor should investigate potential underlying causes including diabetes, antibiotic use, hormonal changes, or immune system factors.

Fuentes

La información médica de esta página se basa en las siguientes fuentes:

• European Medicines Agency (EMA). Clotrimazole — Summary of Product Characteristics. Disponible en: ema.europa.eu
• World Health Organization (WHO). WHO Model List of Essential Medicines. 22nd edition, 2021. who.int
• European STI Guidelines Editorial Board. 2018 European guideline on the management of vulvovaginal candidiasis. Journal of the European Academy of Dermatology and Venereology.

Este contenido se revisa periódicamente para reflejar las directrices clínicas actualizadas. Se proporciona únicamente con fines informativos y no constituye asesoramiento médico. Consulte siempre a un profesional sanitario cualificado para obtener asesoramiento relevante para sus circunstancias de salud individuales.